Search Results
Jul 09, 2026, 05:30 ET Foresee Pharmaceuticals Appoints Brian J. Groch as Chief Commercial Officer to Spearhead Commercial Launch of FP-001 42 mg for Central Precocious Puberty
of industry background and experience in the pharmaceutical industry including multiple leadership roles at Remi Therapeutics, Shield Therapeutics, Veru Inc., and Horizon Therapeutics. He has many years of experience leading global market access strategies and commercial
More news about: Foresee Pharmaceuticals Co., Ltd.
Feb 10, 2026, 17:31 ET PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight
companies, including Merck, Arvinas, Olema Pharmaceuticals, Celcuity, Roche, AstraZeneca, Daiichi Sankyo, Eli Lilly, Sermonix Pharmaceuticals, Genentech, Veru Pharma, DualityBio, BioNtech, Evgen Pharma, Carrick Therapeutics, EQRx, G1 Therapeutics, Immutep, and others.About DelveInsightDelveInsight
More news about: DelveInsight Business Research LLP
Jan 28, 2026, 17:31 ET DUB Inhibitors Market to Witness Strong Expansion Across 7MM by 2040 Driven by the Launch of Novel Therapeutics | DelveInsight
historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key breast cancer companies, including Veru, Sanofi, Roche, AstraZeneca, Eli Lilly, EQRx, Gilead, Sermonix Pharmaceuticals, Evgen Pharma, Tyme, Genentech, Daiichi Sankyo, and others.About DelveInsightDelveInsight
More news about: DelveInsight Business Research, LLP
Nov 13, 2025, 17:31 ET ObesityWeek 2025: Breakthrough Results Reshaping the Obesity Market Landscape | DelveInsight
several other pharma companies involved in obesity treatment research and innovation, including Ro, Hengrui Pharma, Kailera Therapeutics, MetaVia, Veru, Currax Pharmaceuticals, Biomea Fusion, and Aion Medicines, among others. Ro, a direct-to-patient
More news about: DelveInsight Business Research, LLP
Oct 30, 2025, 10:33 ET Global Condom Market to Grow at 8.9% During 2026-32, Driven by Rising Awareness of Sexual Health and Contraceptive Use - MarkNtel Advisors
Church & Dwight Co., Inc., Karex Berhad, LELO iAB, Lifestyles, Veru Inc., Okamoto Industries, Inc., MAYER LABORATORIES, INC., Cupid Limited,
More news about: MarkNtel Advisors
Sep 29, 2025, 17:31 ET DNA Synthesis Inhibitors Market Gains Momentum with Growing Adoption in Oncology and Virology | DelveInsight
historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key breast cancer companies, including Veru, Sanofi, Roche, AstraZeneca, Eli Lilly, EQRx, Gilead, Sermonix Pharmaceuticals, Evgen Pharma, Tyme, Genentech, among others.
More news about: DelveInsight Business Research, LLP
Sep 16, 2025, 17:31 ET KAT6 Inhibitors Market Poised for Significant Growth During the Forecast Period (2025-2040) | DelveInsight
Stemline Therapeutics, Olema Pharmaceuticals, Arvinas, Immutep, AstraZeneca, Roche, Genentech, Evexta Bio, EQRx, Sermonix Pharmaceuticals, Celcuity, Veru Pharma, Evgen Pharma, Eli Lilly, Biotheryx, among others.
More news about: DelveInsight Business Research, LLP